THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA

Gönüllü, E.Kalyoncu, U.Yağız, B.Ateş, A.Küçükşahin, O.Bilge, N. S. YaşarKanitez, N. A.Mercan, Rıdvan2023-05-062023-05-0620220003-49671468-2060https://doi.org/10.1136/annrheumdis-2022-eular.2721https://hdl.handle.net/20.500.11776/12134EULAR European Congress of Rheumatology (EULAR) -- JUN 01-04, 2022 -- Copenhagen, DENMARK[Abstract Not Available]en10.1136/annrheumdis-2022-eular.2721info:eu-repo/semantics/openAccessTHE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATAConference Object8113041304Q1WOS:000850279005213